Cargando…
Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs
Despite the development of therapeutic modalities to treat cancer, multidrug resistance (MDR) and incomplete destruction of deeply embedded lung tumors remain long-standing problems responsible for tumor recurrence and low survival rates. Therefore, developing therapeutic approaches to treat MDR tum...
Autores principales: | Park, Jun-Young, Lee, Gyu-Ho, Yoo, Kwai Han, Khang, Dongwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835376/ https://www.ncbi.nlm.nih.gov/pubmed/36635755 http://dx.doi.org/10.1186/s12951-023-01768-8 |
Ejemplares similares
-
Nanodrugs: optimism for emerging trend of multidrug resistance
por: Khan, Asad U
Publicado: (2012) -
Structural Deformation of MTX Induced by Nanodrug Conjugation Dictate Intracellular Drug Transport and Drug Efficacy
por: Park, Jun-Young, et al.
Publicado: (2021) -
Nanodrug delivery in reversing multidrug resistance in cancer cells
por: Kapse-Mistry, Sonali, et al.
Publicado: (2014) -
Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug‐Conjugated Stealth Mesenchymal Stem Cells
por: Kim, Sang‐Woo, et al.
Publicado: (2018) -
Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
por: Huang, Ping, et al.
Publicado: (2019)